Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China
Peking University Cancer Hospital, Beijing, Beijing, China
Peking University School and Hospital of Stomatology, Beijing, Beijing, China
Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, Beijing, China
Guizhou Provincial People's Hospital, Guiyang, Guizhou, China
Hebei Medical University Forth Hospital, Shijiazhuang, Hebei, China
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Uludag University, Bursa, Turkey
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.